- Filed
- Nov 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 12, 2025 | 12.35M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 11.51M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 9.98M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 6.65M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 5.02M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $573.99K |
| Capex | Q3 2025 · Sep 30, 2024 | $2.12M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$5.06M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$3.26M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $0 |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $0 |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $5.11M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $3.54M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $2.34M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $1.52M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $1.98M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $2.21M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $3.34M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $8.81M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $9.54M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $10.51M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $5.46M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $4.92M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $14.66M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $12.86M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.14 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.41 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.19 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.65 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.14 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.41 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.19 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.65 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $897.51K |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $2.2M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $316.69K |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $666.6K |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $208.27K |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $14.35K |
| Net Income | Q3 2025 · Sep 30, 2025 | −$1.57M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$4.09M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$1.27M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$3.26M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$1.43M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$3.46M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$903.16K |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$2.75M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | $569.55K |
| Gross Profit | Q3 2025 · Sep 30, 2025 | $1.73M |
| Gross Profit | Q3 2025 · Sep 30, 2024 | $336.34K |
| Gross Profit | Q3 2025 · Sep 30, 2024 | $768.69K |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $2.65M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $7.98M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $1.85M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $4.24M |
| Revenue | Q3 2025 · Sep 30, 2025 | $3.22M |
| Revenue | Q3 2025 · Sep 30, 2025 | $9.71M |
| Revenue | Q3 2025 · Sep 30, 2024 | $2.18M |
| Revenue | Q3 2025 · Sep 30, 2024 | $5.01M |